0.889
-0.04 (-4.15%)
| Previous Close | 0.928 |
| Volume | 1,564,898 |
| Price / Sales | 47.26 |
| Price / Book | 6.41 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -0.770 |
| Total Debt/Equity (MRQ) | 416.80% |
| Current Ratio (MRQ) | 4.66 |
| Operating Cash Flow (TTM) | -33.87 M |
| Levered Free Cash Flow (TTM) | -19.45 M |
| Return on Assets (TTM) | -41.29% |
| Return on Equity (TTM) | -307.27% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Milestone Pharmaceuticals Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR). |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 4.71% |
| % Held by Institutions | 22.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Pavaki Capital Management Llc | 30 Jun 2026 | 9,067,848 |
| Simplify Asset Management Inc. | 30 Jun 2026 | 3,349,379 |
| Lion Point Capital, Lp | 30 Jun 2026 | 820,000 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |